Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Neurology

Do I Need a PPI With Indomethacin for Hemicrania Continua?

At a Glance

A proton-pump inhibitor (PPI) is not automatically required for everyone taking long-term indomethacin for hemicrania continua, but it is often advised when ulcer or bleeding risk is moderate or high. Kidney function and blood pressure still need monitoring.

In this answer

5 sections

01

Understanding Your Risk

02

Urgent Warning Signs

03

Alternatives: Misoprostol and H2 Blockers

04

Duration and Review of Treatment

05

What Gastroprotection Can’t Do

A proton-pump inhibitor (PPI) is not automatically mandatory for every person taking long-term indomethacin, but it is commonly recommended to protect against stomach ulcers and bleeding [1][2]. Because indomethacin is a nonsteroidal anti-inflammatory drug (NSAID), taking it every day for hemicrania continua carries a cumulative risk of damaging the lining of your stomach or intestines. While patients at high risk of gastrointestinal complications are strongly advised to take a PPI, even younger patients without obvious risk factors should actively discuss stomach protection with their doctor due to the daily, long-term nature of indomethacin treatment [2][3].

Understanding Your Risk

The decision to prescribe a stomach-protecting medicine is based on factors that raise your likelihood of developing a peptic ulcer (a sore in the stomach or intestinal lining) or dangerous bleeding. Your doctor will likely recommend a PPI if you have any of the following risk factors [4][5]:

  • A history of ulcers: Having had a stomach ulcer or gastrointestinal bleeding in the past is one of the strongest predictors of future problems [6].
  • Age over 65: The stomach lining becomes more vulnerable to NSAID damage as we get older [4].
  • High indomethacin doses: The risk of ulcers increases with higher doses and longer durations of indomethacin [7].
  • Concurrent medications: Taking other drugs that affect bleeding or irritate the stomach lining significantly increases your risk. This includes low-dose aspirin, blood thinners (anticoagulants), corticosteroids, and certain antidepressants known as SSRIs (selective serotonin reuptake inhibitors) [8][5]. Never stop taking prescribed aspirin, antidepressants, or blood thinners without your doctor’s guidance.
  • H. pylori infection: This common stomach bacteria increases the risk of ulcers. Your doctor may test for and treat this infection before or during long-term indomethacin therapy [9][10].

If you have moderate or high risk factors, clinical guidelines strongly advise taking a daily PPI to reduce the chance of serious bleeding [1][11]. You should also avoid adding over-the-counter NSAIDs (like ibuprofen or naproxen) to your indomethacin, as this drastically increases toxicity [12].

Urgent Warning Signs

Because a PPI lowers your risk of bleeding but does not eliminate it entirely, it is critical to know when to seek emergency medical care. Go to an emergency room or seek urgent medical attention if you experience:

  • Black, tarry, or bloody stools
  • Vomiting blood or material that looks like coffee grounds
  • Severe or worsening abdominal pain
  • Fainting, extreme dizziness, or unusual weakness
  • Sudden shortness of breath or chest pain
  • A sudden drop in how much you urinate, or new, rapid swelling in your legs (which can indicate acute kidney strain)

Alternatives: Misoprostol and H2 Blockers

While PPIs (such as omeprazole, pantoprazole, or esomeprazole) have the most robust evidence for preventing NSAID-associated ulcers, there are alternatives if you cannot tolerate them [13][3].

  • Misoprostol: This medication replaces the protective prostaglandins (chemicals that protect the stomach lining) that NSAIDs block. It is highly effective at reducing ulcer complications [14]. However, it often causes cramping and diarrhea, which limits its use for many patients [15][16]. Importantly, misoprostol is contraindicated for ulcer prevention during pregnancy. It can cause uterine contractions, miscarriage, and severe birth defects. Anyone who could become pregnant needs appropriate counseling and reliable contraception before using it [17][18].
  • H2-Receptor Antagonists (H2 blockers): Medications like famotidine reduce stomach acid and offer some protection, but evidence suggests they are less effective than PPIs at preventing serious upper gastrointestinal bleeding in high-risk NSAID users [19][20]. You should not substitute an over-the-counter standard dose of an H2 blocker for a prescribed PPI, as it will not provide equivalent protection.

Duration and Review of Treatment

If you are prescribed a PPI to protect your stomach, you should not assume you will stay on the exact same dose forever. Medical guidelines recommend that long-term PPI therapy should be periodically reviewed by your doctor [2]. The goal is to use the lowest effective dose needed to protect your stomach while you remain on indomethacin [21].

Do not stop taking your PPI abruptly on your own, as this can cause a rebound in stomach acid. If you and your neurologist eventually find a way to stop or significantly lower your indomethacin dose, you should ask your doctor if your PPI can also be carefully reduced or stopped [22][21].

What Gastroprotection Can’t Do

It is crucial to understand that PPIs and other stomach medicines only protect the upper gastrointestinal tract (the stomach and the very beginning of the small intestine). They do not offer total protection against all indomethacin side effects [23].

  • Lower GI Damage: PPIs do not prevent NSAID-induced damage or bleeding in the lower intestines or colon [24]. Note that while some studies suggest an association between PPIs and minor small-bowel injury during NSAID use, this is not a reason to avoid a PPI if its upper-GI benefits are medically indicated [25].
  • Kidney Toxicity: Indomethacin can reduce blood flow to the kidneys, potentially leading to acute or chronic kidney injury [26]. A PPI does not protect your kidneys. You will need baseline and periodic blood tests to monitor your kidney function and check for anemia [1].
  • Cardiovascular Issues: Chronic NSAID use can cause fluid retention, increase blood pressure, and elevate the risks of heart attack, stroke, and worsening heart failure [27]. A PPI does nothing to mitigate these cardiovascular risks, so baseline and periodic blood pressure checks remain essential [26].

Common questions in this guide

Do I need a proton-pump inhibitor with long-term indomethacin for hemicrania continua?
Not everyone taking long-term indomethacin needs a proton-pump inhibitor, but it is often recommended when the risk of an ulcer or gastrointestinal bleeding is moderate or high. Even people without obvious risk factors should discuss stomach protection because daily, long-term use can damage the stomach or intestines.
What makes stomach protection especially important when taking indomethacin?
The risk is higher if you have had an ulcer or gastrointestinal bleeding, are over 65, take a high indomethacin dose, or use medicines such as aspirin, blood thinners, corticosteroids, or SSRI antidepressants. H. pylori infection and taking another NSAID, such as ibuprofen or naproxen, can also increase the risk.
Should I be tested for H. pylori before taking indomethacin long term?
H. pylori can increase the chance of an ulcer during long-term indomethacin treatment. Ask your clinician whether testing and treatment are appropriate based on your medical history and gastrointestinal risk.
Can famotidine or misoprostol replace a PPI with indomethacin?
Misoprostol and H2 blockers such as famotidine may be alternatives when a PPI is not tolerated, but they are not equivalent in every situation. Standard-dose over-the-counter H2 blockers may provide less protection than a prescribed PPI for people at high risk, and misoprostol can cause cramping and diarrhea and must not be used for ulcer prevention during pregnancy.
How long should I take a PPI with long-term indomethacin?
If a PPI is prescribed, your clinician should review it periodically and use the lowest effective dose needed while you remain on indomethacin. Do not stop it abruptly without medical guidance because stomach acid can rebound; ask whether it can be reduced if your indomethacin dose is lowered or stopped.
Does a PPI protect my kidneys or heart from indomethacin?
No. A PPI mainly reduces upper gastrointestinal ulcer and bleeding risk; it does not prevent kidney injury, lower-intestinal damage, high blood pressure, fluid retention, heart attack, stroke, or worsening heart failure from indomethacin. Your clinician may monitor kidney function, blood counts, blood pressure, and symptoms during treatment.
What symptoms require urgent medical care while taking indomethacin?
Seek urgent care for black or bloody stools, vomiting blood or coffee-ground material, severe abdominal pain, fainting, extreme dizziness, chest pain, or sudden shortness of breath. A sudden decrease in urination or new rapid leg swelling can also signal a serious problem and needs prompt medical attention.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Related questions

How Common Is Hemicrania Continua? Age and Sex Patterns How Is the Indomethacin Trial Done for Hemicrania Continua? Can Hemicrania Continua Change Sides or Have Pain-Free Gaps? Hemicrania Continua Flares: How Long, What Triggers Them? What Causes Hemicrania Continua? Genetic or Contagious?
Show more
Is Long-Term Indomethacin Risky for Hemicrania Continua? Can Hemicrania Continua Occur With Migraine Attacks? What Does a Brain MRI Check for Hemicrania Continua? Can Hemicrania Continua Eye Symptoms Mimic Glaucoma? What Does a Normal MRI Mean for Hemicrania Continua? Does Partial Indomethacin Relief Mean Hemicrania Continua? When Are Advanced Scans Needed for Hemicrania Continua? Are Eye or Nose Symptoms Needed for Hemicrania Continua? Missed Indomethacin Dose in Hemicrania Continua: What Now? Can Medication-Overuse Headache Mimic Hemicrania Continua? Do I Need a Lumbar Puncture for Hemicrania Continua? Which Indomethacin Form Is Best for Hemicrania Continua? How Is Indomethacin Monitored in Hemicrania Continua? What Should I Track in a Hemicrania Continua Diary?

Get notified when new evidence is published on Hemicrania continua.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my indomethacin dose and medical history, what is my specific risk level for a stomach ulcer or bleeding?
  2. 2.Should I be tested for an H. pylori infection before committing to long-term indomethacin therapy?
  3. 3.If I am prescribed a PPI, how often should we review the dosage to ensure I am taking the lowest effective amount?
  4. 4.How often will we check my kidney function and blood pressure while I remain on long-term indomethacin?

References

References (27)
  1. 1

    Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.

    Szeto CC, Sugano K, Wang JG, et al.

    Gut 2020; (69(4)):617-629 doi:10.1136/gutjnl-2019-319300.

    PMID: 31937550
  2. 2

    The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.

    Freedberg DE, Kim LS, Yang YX

    Gastroenterology 2017; (152(4)):706-715 doi:10.1053/j.gastro.2017.01.031.

    PMID: 28257716
  3. 3

    Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.

    Yang M, He M, Zhao M, et al.

    Current medical research and opinion 2017; (33(6)):973-980 doi:10.1080/03007995.2017.1281110.

    PMID: 28076696
  4. 4

    The Mexican consensus on the diagnosis, treatment, and prevention of NSAID-induced gastropathy and enteropathy.

    Bielsa-Fernández MV, Tamayo-de la Cuesta JL, Lizárraga-López J, et al.

    Revista de gastroenterologia de Mexico (English) 2020; (85(2)):190-206 doi:10.1016/j.rgmx.2019.11.003.

    PMID: 32094057
  5. 5

    Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO).

    Abrignani MG, Gatta L, Gabrielli D, et al.

    European journal of internal medicine 2021; (85()):1-13 doi:10.1016/j.ejim.2020.11.014.

    PMID: 33279389
  6. 6

    Evidence-based clinical practice guidelines for peptic ulcer disease 2020.

    Kamada T, Satoh K, Itoh T, et al.

    Journal of gastroenterology 2021; (56(4)):303-322 doi:10.1007/s00535-021-01769-0.

    PMID: 33620586
  7. 7

    Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital.

    Lee HL, Chua SS, Mahadeva S

    Therapeutics and clinical risk management 2016; (12()):1649-1657 doi:10.2147/TCRM.S119722.

    PMID: 27877048
  8. 8

    Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.

    Venerito M, Schneider C, Costanzo R, et al.

    Alimentary pharmacology & therapeutics 2018; (47(11)):1464-1471 doi:10.1111/apt.14652.

    PMID: 29655196
  9. 9

    Helicobacter pylori Eradication in Drug-related Peptic Ulcer.

    Joo MK

    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2020; (76(5)):227-231 doi:10.4166/kjg.2020.141.

    PMID: 33234768
  10. 10

    Prevention of Peptic Ulcer Associated with Aspirin and Antiplatelet Agent.

    Ahn JY

    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2020; (76(5)):238-241 doi:10.4166/kjg.2020.140.

    PMID: 33234770
  11. 11

    Practice Advisory on the Appropriate Use of NSAIDs in Primary Care.

    Ho KY, Cardosa MS, Chaiamnuay S, et al.

    Journal of pain research 2020; (13()):1925-1939 doi:10.2147/JPR.S247781.

    PMID: 32821151
  12. 12

    Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies.

    Goldstein JL, Cryer B

    Drug, healthcare and patient safety 2015; (7()):31-41 doi:10.2147/DHPS.S71976.

    PMID: 25653559
  13. 13

    Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia.

    Garegnani L, Oltra G, Burgos MA, et al.

    The Cochrane database of systematic reviews 2025; (5()):CD014585 doi:10.1002/14651858.CD014585.pub2.

    PMID: 40337979
  14. 14

    Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity.

    Yuan JQ, Tsoi KK, Yang M, et al.

    Alimentary pharmacology & therapeutics 2016; (43(12)):1262-75 doi:10.1111/apt.13642.

    PMID: 27121479
  15. 15

    Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Taha AS, McCloskey C, McSkimming P, McConnachie A

    The lancet. Gastroenterology & hepatology 2018; (3(7)):469-476 doi:10.1016/S2468-1253(18)30119-5.

    PMID: 29754836
  16. 16

    Comparing the efficacy and safety of medications to prevent nonsteroidal anti-inflammatory drug-induced ulcers in high-risk patients: A network meta-analysis.

    Huang X, Fang Q, Zhou L, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2026; (58(2)):197-205 doi:10.1016/j.dld.2025.11.012.

    PMID: 41423403
  17. 17

    Misoprostol exposure during the first trimester of pregnancy: Is the malformation risk varying depending on the indication?

    Auffret M, Bernard-Phalippon N, Dekemp J, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2016; (207()):188-192 doi:10.1016/j.ejogrb.2016.11.007.

    PMID: 27865944
  18. 18

    Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open-Label, Randomized, Single-dose, Crossover Study With Healthy Chinese Volunteers.

    Wang S, Wu F, Han Y, et al.

    Clinical pharmacology in drug development 2022; (11(8)):949-956 doi:10.1002/cpdd.1102.

    PMID: 35486088
  19. 19

    Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.

    Scally B, Emberson JR, Spata E, et al.

    The lancet. Gastroenterology & hepatology 2018; (3(4)):231-241 doi:10.1016/S2468-1253(18)30037-2.

    PMID: 29475806
  20. 20

    Impact of Preventive Strategies on Gastrointestinal Complications in Elderly Patients on Concomitant Use of Oral Anticoagulants and Nonsteroidal Anti-Inflammatory Drugs: A Nationwide Cohort Study.

    Lee S, Heo KN, Lee MY, et al.

    Drug safety 2022; (45(3)):297-304 doi:10.1007/s40264-022-01150-x.

    PMID: 35184258
  21. 21

    Cost-Utility and Budget Impact Analysis for Stopping the Inappropriate Use of Proton Pump Inhibitors After Cessation of NSAID or Low-Dose Acetylsalicylic Acid Treatment.

    Chau SH, Sluiter RL, Hugtenburg JG, et al.

    Drugs & aging 2020; (37(1)):67-74 doi:10.1007/s40266-019-00713-5.

    PMID: 31560115
  22. 22

    Peptic Ulcer Disease: A Review.

    Vakil N

    JAMA 2024; (332(21)):1832-1842 doi:10.1001/jama.2024.19094.

    PMID: 39466269
  23. 23

    Proton pump inhibitors: use and misuse in the clinical setting.

    Savarino V, Marabotto E, Zentilin P, et al.

    Expert review of clinical pharmacology 2018; (11(11)):1123-1134 doi:10.1080/17512433.2018.1531703.

    PMID: 30295105
  24. 24

    Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits.

    Lué A, Lanas A

    World journal of gastroenterology 2016; (22(48)):10477-10481 doi:10.3748/wjg.v22.i48.10477.

    PMID: 28082800
  25. 25

    Proton Pump Inhibitors Increase the Risk of Nonsteroidal Anti-inflammatory Drug-Related Small-Bowel Injury: A Systematic Review With Meta-analysis.

    Zhang X, Xiao X, Chen PR, et al.

    Clinical and translational gastroenterology 2023; (14(6)):e00588 doi:10.14309/ctg.0000000000000588.

    PMID: 37019683
  26. 26

    Acute kidney injury associated with non-steroidal anti-inflammatory drugs.

    Klomjit N, Ungprasert P

    European journal of internal medicine 2022; (101()):21-28 doi:10.1016/j.ejim.2022.05.003.

    PMID: 35534373
  27. 27

    NSAIDs in CKD: Are They Safe?

    Baker M, Perazella MA

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2020; (76(4)):546-557 doi:10.1053/j.ajkd.2020.03.023.

    PMID: 32479922

This page explains stomach protection and safety monitoring during long-term indomethacin treatment for hemicrania continua; it is for education, not medical advice. Your neurologist or prescribing clinician should decide whether you need a PPI and how to monitor you.